Beijing Will Soon Promulgate New Changes In Medical Policy
This article was originally published in PharmAsia News
Executive Summary
Xiangyang Ding, Beijing deputy mayor, announced Jan. 26 that the city will introduce a new round of changes in medical policy in the first half of 2010
You may also be interested in...
Achillion Sends HBV, HIV Treatment Elovucitabine To China
SHANGHAI - Achillion announced Feb. 1 it has outlicensed elvucitabine, its compound for hepatitis B virus and human immunodeficiency virus, to GCA Therapeutics in China
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.